Leonard S. Schleifer - Bd. Co-Chair, President & CEO, Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Bd. Co-Chair, President & CEO, Director
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Leonard S. Schleifer - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by Leonard S. Schleifer for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 467K $479M $1,025.27 Jun 11, 2024 Direct
Common Stock 158K $162M $1,025.27 Jun 11, 2024 2023 GRAT
Common Stock 40K $40.6M $1,016.62 Jun 12, 2024 By Trust
Common Stock 5.93K $6.08M $1,025.27 Jun 11, 2024 By 401(k) Plan
Common Stock 0 $0 $1,025.27 Jun 12, 2024 by Trust for Son
Class A Stock 1.71M Jun 11, 2024 Direct Common Stock 1.71M
Class A Stock 14.8K Jun 12, 2024 by Trust for Son Common Stock
2019 Performance Stock Units 0 $844.09 Dec 11, 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 May 13, 2024 Direct Common Stock

Transactions reported by Leonard S. Schleifer for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.